Finance

Lists
4019:TADAWUL
Specialized Medical Company SCJSC
SAR 12.55
-0.40%
(-0.050) 1D
Nov 19, 3:13:56 PM GMT+3  ·   SAR
All symbols
SymbolPriceChange% Change
Generating top insights for 4019...
Open
SAR 12.55
High
SAR 12.57
Low
SAR 12.39
Mkt. cap
3.14B
Avg. vol.
799.70K
Volume
215.34K
Dividend
2.55%
Quarterly dividend
SAR 0.08
Ex-dividend date
May 18, 2026
P/E ratio
12.37
52-wk high
SAR 21.49
52-wk low
SAR 11.34
EPS
SAR 1.01
Shares outstanding
246.47M
No. of employees
3K
Open
SAR 12.55
High
SAR 12.57
Low
SAR 12.39
Mkt. cap
3.14B
Avg. vol.
799.70K
Volume
215.34K
Dividend
2.55%
Quarterly dividend
SAR 0.08
Ex-dividend date
May 18, 2026
P/E ratio
12.37
52-wk high
SAR 21.49
52-wk low
SAR 11.34
EPS
SAR 1.01
Shares outstanding
246.47M
No. of employees
3K
News stories
From web sources and news partners
About Specialized Medical Company SCJSC
CEO-
Employees3.35K
Founded1994
Headquarters-
SectorHealth Care
IndustryHealth care provider
Websitesmc.com.sa
Previous reportsAll values in SAR
Loading Previous Earnings...
Revenue
Net income
All values in SAR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
406.91M
380.67M
401.33M
401.09M
Cost of goods sold
323.31M
289.71M
301.20M
306.41M
Cost of revenue
323.31M
289.71M
301.20M
306.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.77M
49.88M
44.59M
41.79M
Operating expense
11.77M
49.88M
44.59M
41.79M
Total operating expenses
335.08M
339.59M
345.79M
348.20M
Operating income
71.83M
41.08M
55.53M
52.89M
Other non operating income
7.21M
2.98M
2.82M
1.56M
EBT including unusual items
134.75M
33.70M
46.66M
43.78M
EBT excluding unusual items
74.12M
33.70M
46.66M
43.78M
Income tax expense
766.56K
1.15M
1.48M
1.88M
Effective tax rate
0.57%
3.42%
3.17%
4.30%
Other operating expenses
-
-
-
-
Net income
133.98M
32.55M
45.18M
41.90M
Net profit margin
32.93%
8.55%
11.26%
10.45%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-4.92M
-10.36M
-11.70M
-10.66M
Net interest expenses
-4.92M
-10.36M
-11.70M
-10.66M
Depreciation and amortization charges
-
-
-
-
EBITDA
87.47M
57.71M
71.89M
69.12M
Gain or loss from assets sale
-60.66M
-
-
-26.11K
Upcoming events
AI content may include mistakes. Learn more
Google apps